2019 Press Releases
2018 Press Releases
March 22, 2018
Lonza and BioWa Sign POTELLIGENT® CHOK1SVTM Cell Line Technology Licensing Agreement with Tillotts Pharma AG ![PDF file:New window opens](/biowa/share/images/btn_pdf.gif)
2016 Press Releases
October 18, 2016
Kyowa Hakko Kirin and BioWa File Suit in the U.S. to Defend Patent Rights on POTELLIGENT® Technology ![PDF file:New window opens](/biowa/share/images/btn_pdf.gif)
April 1, 2016
BioWa Announces Office Relocation to Princeton, NJ and appointment of New President and CEO ![PDF file:New window opens](/biowa/share/images/btn_pdf.gif)
January 11, 2016
BioWa opens POTELLIGENT® Technology license to customers for creating POTELLIGENT® cell lines ![PDF file:New window opens](/biowa/share/images/btn_pdf.gif)
2015 Press Releases
June 26, 2015
Cantargia licenses BioWa POTELLIGENT® Technology platform for production of lead product candidate ![PDF file:New window opens](/biowa/share/images/btn_pdf.gif)
February 16, 2015
Transfer of BioWa's "External Innovation Engine" In-Licensing Activities to Kyowa Hakko Kirin California ![PDF file:New window opens](/biowa/share/images/btn_pdf.gif)
2014 Press Releases
March 19, 2014
Lonza and BioWa Sign POTELLIGENT® CHOK1SV Cell Line Technology Licensing Agreement with arGEN-X ![PDF file:New window opens](/biowa/share/images/btn_pdf.gif)
2013 Press Releases
December 11, 2013
Lonza and BioWa Sign POTELLIGENT® CHOK1SV Cell Line Technology
Licensing Agreement with MedImmune ![PDF file:New window opens](/biowa/share/images/btn_pdf.gif)
July 30, 2013
BioWa and Lonza Sign License Agreements with Pfizer ![PDF file:New window opens](/biowa/share/images/btn_pdf.gif)
March 18, 2013
BioWa Relocates to La Jolla, CA ![PDF file:New window opens](/biowa/share/images/btn_pdf.gif)
2012 Press Releases
2011 Press Releases
2010 Press Releases
November 15, 2010
BioWa Announces License of POTELLIGENT Technology to Agensys ![PDF file:New window opens](/biowa/share/images/btn_pdf.gif)
July 26, 2010
Daiichi Sankyo Selects POTELLIGENT CHOK1SV Cell Line ![PDF file:New window opens](/biowa/share/images/btn_pdf.gif)
June 23, 2010
BioWa Announces Expansion of Licenses To Glaxosmithkline ![PDF file:New window opens](/biowa/share/images/btn_pdf.gif)
2009 Press Releases
October 21, 2009
BioWa and NKTT Announce Licensing of BioWa Potelligent Tech for use in Antibody R&D ![PDF file:New window opens](/biowa/share/images/btn_pdf.gif)
October 5, 2009
BioWa Announces Second Japanese License of Potelligent® Technology To Otsuka Pharmaceutical ![PDF file:New window opens](/biowa/share/images/btn_pdf.gif)
July 29, 2009
BioWa Appoints New Vice President, Corporate Development ![PDF file:New window opens](/biowa/share/images/btn_pdf.gif)
2008 Press Releases
Dec. 8, 2008
BioWa Licenses Potelligent® Technology To Glaxosmithkline For Use In Antibody Development And Commercialization ![PDF file:New window opens](/biowa/share/images/btn_pdf.gif)
Oct. 28, 2008
BioWa Announces License Of BioWa's Potelligent® Technology To Kalobios Pharmaceuticals ![PDF file:New window opens](/biowa/share/images/btn_pdf.gif)
2007 Press Releases
July 23rd, 2007
Phase 1 Interim Clinical Study Data Released Regarding Mild Asthma Anti-Il-5 Receptor Mab
May 30, 2007